Results 241 to 250 of about 2,968,352 (265)
Some of the next articles are maybe not open access.
Repositioning of dexamethasone intravitreal implant (Ozurdex®) migrated into the anterior chamber
International Ophthalmology, 2012Ozurdex (Allergan Inc., Irvine, CA, USA) is a biodegradable implant of dexamethasone (0.7 mg) injected into the vitreous cavity to treat macular oedema. We report a case of migration of Ozurdex into the anterior chamber in a patient who had a previous iris-claw lens implantation.
José I, Vela +2 more
openaire +2 more sources
Migration of Glaucoma Drainage Device Extender Into Anterior Chamber After Trauma
Journal of Glaucoma, 2006Glaucoma drainage devices, on rare occasions, need repositioned and the intraocular portion of the implant tube is found to be "too short" to do so. Previously, a technique was described for "extending" the tube with angiocatheter material (rather than replacing the entire apparatus), and had been performed successfully without complication for 7 years.
Clinton W, Sheets +3 more
openaire +2 more sources
Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®)
Graefe's Archive for Clinical and Experimental Ophthalmology, 2011Dear Editor, Ozurdex® (Allergan Inc., Irvine, CA, USA) is an intravitreal implant containing the dexamethasone. It uses NOVADUR® drug delivery technology, in which a biodegradable material is combined with the active drug dexamethasone to form a small rod-shaped implant of 0.46 mm in diameter and 6 mm in length.
Diamar Pardo-López +3 more
openaire +1 more source
Progressive intraluminal stent migration into the anterior chamber
Clinical & Experimental Ophthalmology, 2019Corey Rowland +3 more
openaire +5 more sources
Dexamethasone Implant Anterior Chamber Migration
Ophthalmology, 2014Rahul N. Khurana +7 more
openaire +1 more source
Anterior Chamber Migration of Fluocinolone Acetonide Intravitreal Implant
JAMA Ophthalmology, 2019Pukhraj, Rishi +2 more
openaire +2 more sources
Ocular Immunology and Inflammation, 2018
The dexamethasone intravitreal implant poses a risk to the cornea if it migrates into the anterior chamber. Because it tends to fracture if grasped with surgical instruments, no-touch techniques represent the most successful means of removing the device from the eye. The present report describes a new approach in which the implant is aspirated into the
openaire +1 more source
The dexamethasone intravitreal implant poses a risk to the cornea if it migrates into the anterior chamber. Because it tends to fracture if grasped with surgical instruments, no-touch techniques represent the most successful means of removing the device from the eye. The present report describes a new approach in which the implant is aspirated into the
openaire +1 more source
Migration of Capsular Bag into the Anterior Chamber: Photo Essay
2023Saeed Karimi +2 more
openaire +1 more source
Journal francais d'ophtalmologie, 2013
We report the case of anterior chamber migration of a dexamethasone implant (Ozurdex(®)) in a 54-year-old woman with macular edema due to a central retinal vein occlusion. The patient had undergone complicated cataract surgery 5 years previously with a scleral-fixated posterior chamber lens implant.
O, Laplace +3 more
openaire +1 more source
We report the case of anterior chamber migration of a dexamethasone implant (Ozurdex(®)) in a 54-year-old woman with macular edema due to a central retinal vein occlusion. The patient had undergone complicated cataract surgery 5 years previously with a scleral-fixated posterior chamber lens implant.
O, Laplace +3 more
openaire +1 more source
Anterior Chamber Migration of Dexametasone Intravitreal Implant (Ozurdex®)
Graefe's Archive for Clinical and Experimental Ophthalmology, 2012Manuel Diaz-Llopis
exaly